JPMORGAN CHASE & CO - CASCADIAN THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

CASCADIAN THERAPEUTICS INC's ticker is CASC and the CUSIP is 14740B606. A total of 90 filers reported holding CASCADIAN THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CASCADIAN THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$493,000
+34.3%
133,328
+49.1%
0.00%–
Q3 2017$367,000
+7240.0%
89,413
+6622.8%
0.00%–
Q2 2017$5,000
-90.4%
1,330
-89.4%
0.00%–
Q1 2017$52,000–12,583–0.00%–
 Download
Other shareholders

There were no reported owners of CASCADIAN THERAPEUTICS INC in Q4 2017.

NameSharesValueWeighting ↓
View complete list of CASCADIAN THERAPEUTICS INC shareholders